SIX MONTHS' TREATMENT WITH MIV-711, A NOVEL CATHEPSIN K INHIBITOR INDUCES OSTEOARTHRITIS STRUCTURE MODIFICATION: RESULTS FROM A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE IIA TRIAL

著录项

• 来源
  《Osteoarthritis and cartilage》 |2018年第1期|共2页
• 作者

  Conaghan P. G.; Bowes M. A.; Kingsbury S. R.; Brett A.; Guillard G.; Tunblad K.; Rizoska B.; Larsson T.; Holmgren A.; Manninen A.; Gohlin K.; Heber W.; Graham P.; Jansson A.; Wadell C.; Bethell R.; Ohd J.;

  展开▼
• 作者单位

  Univ Leeds Leeds W Yorkshire England;

  Imorphics Ltd Manchester Lancs England;

  Univ Leeds Leeds W Yorkshire England;

  Imorphics Ltd Manchester Lancs England;

  Imorphics Ltd Manchester Lancs England;

  Medivir Huddinge Sweden;

  Medivir Huddinge Sweden;

  Medivir Huddinge Sweden;

  Medivir Huddinge Sweden;

  Medivir Huddinge Sweden;

  Medivir Huddinge Sweden;

  PAREXEL Baltimore MD USA;

  Medivir Huddinge Sweden;

  Medivir Huddinge Sweden;

  Medivir Huddinge Sweden;

  Medivir Huddinge Sweden;

  Medivir Huddinge Sweden;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 骨科学（运动系疾病、矫形外科学）;
• 关键词

• 入库时间 2022-08-20 05:25:53